Stockreport

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Techno...

Better Therapeutics, Inc.  (BTTX) 
PDF SAN FRANCISCO, March 04, 2024 BUSINESS WIRE Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating card [Read more]